Concepedia

Publication | Open Access

Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme

DOIFull Paper Access

1.4K

Citations

29

References

2007

Year

James J. Vredenburgh, Annick Desjardins, James E. Herndon, Jennifer Marcello, David A. Reardon, Jennifer A. Quinn, Jeremy N. Rich, Sith Sathornsumetee, Sridharan Gururangan, John H. Sampson,
Journal of Clinical Oncology

Abstract

Bevacizumab and irinotecan is an effective treatment for recurrent glioblastoma multiforme and has moderate toxicity.

References

YearCitations

Page 1